Search research articles
Contact Us
Filters
Showing results (581-590 of 742) with videos related to
Page
of 75
Sort By:
Disability and Rehabilitation
|
January 31, 2020
Strategies used to engage hard-to-reach populations in childhood disability research: a scoping review
Miriam Gonzalez, Michelle Phoenix, Shikha Saxena, et al.
Molecular Pharmaceutics
|
October 15, 2020
Effects of Hydrophobic Tail Length Variation on Surfactant-Mediated Protein Stabilization
Mckenna G Hanson, Joshua S Katz, Hua Ma, et al.
Journal Francais D'Ophtalmologie
|
November 9, 2013
[Hyper-IgG4 disease presenting with lid involvement]
C Basdekidou, O Gout, M Zmuda, et al.
Neuroreport
|
February 19, 2008
Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias
Melanie A Paquette, Elizabeth G Brudney, Daniel B Putterman, et al.
Journal of Neuroimmunology
|
January 6, 2009
Depression is an early disease manifestation in lupus-prone MRL/lpr mice
Hua-Xin Gao, Sean R Campbell, Min-Hui Cui, et al.
Biophysical Journal
|
February 17, 2020
Nanoscale Heat Transfer from Magnetic Nanoparticles and Ferritin in an Alternating Magnetic Field
Hunter C Davis, Sunghwi Kang, Jae-Hyun Lee, et al.
Nature Immunology
|
May 11, 2021
Promise and complexity of lupus mouse models
Erica Moore, Joshua A Reynolds, Anne Davidson, et al.
Clinical Rheumatology
|
June 28, 2011
A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine
Rachel L Gross, Jason Brucker, Asena Bahce-Altuntas, et al.
Autoimmunity Reviews
|
November 2, 2011
Autoantibodies in lupus: culprits or passive bystanders?
Ole P Rekvig, Chaim Putterman, Cinzia Casu, et al.
Journal of Neuroinflammation
|
April 10, 2024
Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL/lpr mouse model of neuropsychiatric lupus
Joshua Reynolds, Michelle Huang, Yaxi Li, et al.
Page
of 75
Search research articles
Search
Showing results (581-590 of 742) with videos related to
Sort By:
Page
of 75
Disability and Rehabilitation
|
January 31, 2020
Strategies used to engage hard-to-reach populations in childhood disability research: a scoping review
Miriam Gonzalez, Michelle Phoenix, Shikha Saxena, et al.
Molecular Pharmaceutics
|
October 15, 2020
Effects of Hydrophobic Tail Length Variation on Surfactant-Mediated Protein Stabilization
Mckenna G Hanson, Joshua S Katz, Hua Ma, et al.
Journal Francais D'Ophtalmologie
|
November 9, 2013
[Hyper-IgG4 disease presenting with lid involvement]
C Basdekidou, O Gout, M Zmuda, et al.
Neuroreport
|
February 19, 2008
Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias
Melanie A Paquette, Elizabeth G Brudney, Daniel B Putterman, et al.
Journal of Neuroimmunology
|
January 6, 2009
Depression is an early disease manifestation in lupus-prone MRL/lpr mice
Hua-Xin Gao, Sean R Campbell, Min-Hui Cui, et al.
Biophysical Journal
|
February 17, 2020
Nanoscale Heat Transfer from Magnetic Nanoparticles and Ferritin in an Alternating Magnetic Field
Hunter C Davis, Sunghwi Kang, Jae-Hyun Lee, et al.
Nature Immunology
|
May 11, 2021
Promise and complexity of lupus mouse models
Erica Moore, Joshua A Reynolds, Anne Davidson, et al.
Clinical Rheumatology
|
June 28, 2011
A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine
Rachel L Gross, Jason Brucker, Asena Bahce-Altuntas, et al.
Autoimmunity Reviews
|
November 2, 2011
Autoantibodies in lupus: culprits or passive bystanders?
Ole P Rekvig, Chaim Putterman, Cinzia Casu, et al.
Journal of Neuroinflammation
|
April 10, 2024
Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL/lpr mouse model of neuropsychiatric lupus
Joshua Reynolds, Michelle Huang, Yaxi Li, et al.
Page
of 75